| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/PR070328S |
| P698 | PubMed publication ID | 17824635 |
| P50 | author | Visith Thongboonkerd | Q41653417 |
| P433 | issue | 10 | |
| P304 | page(s) | 3881-3890 | |
| P577 | publication date | 2007-09-07 | |
| P1433 | published in | Journal of Proteome Research | Q3186939 |
| P1476 | title | Practical points in urinary proteomics | |
| P478 | volume | 6 |
| Q42123037 | "Lossless" compression of high resolution mass spectra of small molecules |
| Q28478586 | A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy |
| Q39486332 | A proteomic evaluation of urinary changes associated with cardiopulmonary bypass |
| Q34115491 | Adipocytokine zinc α2 glycoprotein (ZAG) as a novel urinary biomarker for normo-albuminuric diabetic nephropathy |
| Q38805683 | Adsorption of urinary proteins on the conventionally used urine collection tubes: possible effects on urinary proteome analysis and prevention of the adsorption by polymer coating |
| Q47806771 | Advances in the analysis of "less-conventional" human body fluids: An overview of the CE- and HPLC-MS applications in the years 2015-2017. |
| Q37551660 | Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease |
| Q35423674 | An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis |
| Q33829666 | Analysis of the urinary peptidome associated with Helicobacter pylori infection |
| Q37622063 | Application of proteomic analysis to the study of renal diseases |
| Q34462735 | Before you analyze a human specimen, think quality, variability, and bias |
| Q34125681 | Biomarker discovery in neurodegenerative diseases: a proteomic approach. |
| Q41897818 | CSF Biomarkers for Alzheimer's Disease Diagnosis |
| Q30438814 | Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments |
| Q51794241 | Challenges and opportunities for discovery of disease biomarkers using urine proteomics. |
| Q37050438 | Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform |
| Q37951798 | Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis |
| Q96158999 | Cystatin C, Neutrophil gelatinase-associated lipocalin and Lysozyme C: Urinary biomarkers for detection of early kidney dysfunction in children with urolithiasis |
| Q34964281 | Detection of renal tissue and urinary tract proteins in the human urine after space flight |
| Q34472995 | Development of quantitative proteomics using iTRAQ based on the immunological response of Galleria mellonella larvae challenged with Fusarium oxysporum microconidia |
| Q37267058 | Differential human urinary lipid profiles using various lipid-extraction protocols: MALDI-TOF and LIFT-TOF/TOF analyses |
| Q34413086 | Evaluation of urinary protein precipitation protocols for the multidisciplinary approach to the study of chronic pelvic pain research network |
| Q51462040 | Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. |
| Q51739894 | Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. |
| Q36455680 | Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer |
| Q34571042 | Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS. |
| Q36811800 | Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine |
| Q37137414 | Immunoaffinity capillary electrophoresis as a powerful strategy for the quantification of low-abundance biomarkers, drugs, and metabolites in biological matrices |
| Q34634938 | Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy |
| Q38966497 | Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria |
| Q37810251 | Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids. |
| Q34546734 | Non-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples. |
| Q38326090 | Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications |
| Q36916722 | Optimizing Urine Processing Protocols for Protein and Metabolite Detection |
| Q34214393 | Optimizing a proteomics platform for urine biomarker discovery |
| Q30854221 | Optimizing sample handling for urinary proteomics |
| Q58035975 | PROTEOMICS APPROACHES IN PRE-ECLAMPSIA RESEARCH |
| Q34387861 | Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin |
| Q37068847 | Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease |
| Q39092960 | Physiologic changes of urinary proteome by caffeine and excessive water intake |
| Q47963729 | Preeclamptic toxemia: a disease ripe for proteomic discovery |
| Q37869065 | Profiling the proteome in renal transplantation |
| Q38461516 | Proteome research in urothelial carcinoma. |
| Q92263286 | Proteomic profiling of urine: implications for lupus nephritis |
| Q38190894 | Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies? |
| Q35207579 | Proteomics and opportunities for clinical translation in urological disease |
| Q26829598 | Proteomics and systems biology: current and future applications in the nutritional sciences |
| Q64057142 | Proteomics in Psoriasis |
| Q35599113 | Quantitative mass spectrometry of urinary biomarkers |
| Q42744183 | Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence |
| Q33419196 | SELDI-TOF as a method for biomarker discovery in the urine of aristolochic-acid-treated mice |
| Q33576349 | Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study |
| Q37064920 | Schizophrenia genomics and proteomics: are we any closer to biomarker discovery? |
| Q87195839 | Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men |
| Q33597457 | Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease |
| Q35844134 | Strategy and rationale for urine collection protocols employed in the NEPTUNE study |
| Q28748224 | The application of mass-spectrometry-based protein biomarker discovery to theragnostics |
| Q35671024 | The association of urinary nerve growth factor levels with bladder outlet obstruction in women |
| Q37401369 | The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease |
| Q38217103 | The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques |
| Q34062244 | The urine proteome for radiation biodosimetry: effect of total body vs. local kidney irradiation. |
| Q43939756 | Unveiling the rat urinary proteome with three complementary proteomics approaches |
| Q26799195 | Update on Biomarkers for the Detection of Endometriosis |
| Q37707267 | Urinary biomarkers involved in type 2 diabetes: a review. |
| Q28475613 | Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology |
| Q38502483 | Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. |
| Q33781011 | Urinary proteomics as a novel tool for biomarker discovery in kidney diseases |
| Q38677349 | Urinary proteomics for the study of genetic kidney diseases |
| Q92218747 | Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer |
| Q33780855 | Urine collection and processing for protein biomarker discovery and quantification |
| Q37230698 | Urine in clinical proteomics |
| Q36715758 | Urine proteome of autosomal dominant polycystic kidney disease patients |
| Q35967762 | Urine proteomic analysis in cystinuric children with renal stones |
| Q90295769 | Urine proteomic profiling in patients with nephrolithiasis and cystinuria |
| Q37876853 | Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications |
| Q38240765 | Urine sample preparation for proteomic analysis |
| Q33437720 | Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics |
Search more.